Play Video

OIS

The Ophthalmology Innovation Summit (OIS) was conceptualized and developed by ophthalmologist/venture capitalist Emmett Cunningham of Clarus Funds now Blackstone Life Sciences. To make his vision for OIS a reality, Emmett enrolled legendary venture capitalists, Bill Link of Versant Ventures/Flying L Partners to Co-Chair the summits. The addition of experienced conference producer, Craig Simak brought the event to life in 2009.

Learn More

QUOTE OF THE MONTH

“It is better to light a candle than curse the darkness.” - Eleanor Roosevelt
(referenced by Mark Blumenkranz, MD on his recent OIS Retina Podcast)

EVENT UPDATES

The Ophthalmology Innovation Summits facilitate meaningful interactions and the exchange of information between clinical, capital and corporate leaders to accelerate the development and commercialization of novel therapies to address unmet needs.

LEARN MORE

The event will begin with a market overview followed by a showcase of 8 promising start-ups in this sector, a deep-dive panel discussion with industry executives and a live Q&A with select presenting companies. We will conclude the program with additional networking time.

LEARN MORE

TRENDING AT OIS

Discover the latest trending news, podcasts, videos from OIS covering corporate leaders and innovators.

Dr. Steve Pakola’s Perspective on the Transformative Power of Advanced Therapeutics
October 20, 2020
A Stimulating Conversation with Oxurion CEO Patrik De Haes, MD
October 14, 2020
Rayner CEO Tim Clover Talks about Company’s Future Innovation Plans
October 6, 2020
Impacting Lives with Tomorrow’s Tech
September 30, 2020
Dr. Duker’s Dynamic Career in Retina
September 22, 2020
COVID Can’t Lock Down Innovation in Glaucoma
October 20, 2020
Ocular Therapeutix Makes Lots of Buzz. Wall Street Notices
October 14, 2020
Opthea’s Activity Leads to IPO
October 6, 2020
OIS Showcase Reinforces Europe’s Role in Innovation
September 30, 2020
Despite Tepid Wall Street Response, Outlook Therapeutics Still Betting on Ophthalmic Bevacizumab Formulation
September 22, 2020
Manufacturing Strategy Key to AGTC’s Next Steps for Gene Therapy Programs
August 18, 2020
Osmotica Will Commercialize and Supply Non-Surgical Droopy Lid Treatment via a Wholly Owned Subsidiary
August 5, 2020
AbbVie Regroups after FDA Issues Complete Response Letter Rejecting Abicipar Pegol
July 9, 2020
With Positive Phase III Results, Oyster Point Pharma Banks $120 Million from Public Offering
July 1, 2020
With Fresh Funding, Eyenovia Pursues Platform for Focused Drug Delivery
April 29, 2020
OIS Index Rallies Back from COVID-Driven Decline
July 9, 2020
OIS Index Posts a Strong Finish to 2019
January 9, 2020
OIS Index Outperforms
December 4, 2019
OIS Index on Positive Upswing
November 6, 2019
OIS Index Deep in Bear Territory in Q3
October 2, 2019
Do You Have

A STORY TO TELL?

If you’d like to be considered as a guest on a future episode of the OIS podcast, please complete the application today.

Apply Today

The OIS All Stars of Ophthalmic Innovation

This is the inaugural ranking of individuals working to transform the current state of vision care. The nominees will be reviewed by a committee of OIS faculty, advisors and journalists. Once selected, the list of OIS All Stars will be published and widely promoted. Nominate your colleagues & peers here.

TESTIMONIALS

Why People Attend OIS

Daphne-Haim-Langford-PhD-OIS-Israel

TOM MITRO

PRESIDENT & COO

YARI MITCHELL

VP, GLOBAL MEDICAL AFFAIRS

JAG DOSANJH

SENIOR VICE PRESIDENT

SUBSCRIBE TO OUR NEWSLETTER

Get the Latest News Ophthalimc Innovation To Your Inbox.